Arya Arash, Piorkowski Christopher, Sommer Phillip, Bollmann Andreas, Hindricks Gerhard
Heart Center, Department of Electrophysiology, University of Leipzig, Strümpellstrasse 39, Leipzig, Germany.
Herzschrittmacherther Elektrophysiol. 2008 Jun;19(2):68-72. doi: 10.1007/s00399-008-0003-8. Epub 2008 Jul 13.
Atrial fibrillation (AF) is a common arrhythmia, affecting an estimated 2 million people in the United States and its prevalence increases with age, reaching 10% in those > or = 80 years. AF confers a four- to fivefold increased risk of stroke compared to the general population and has been associated with a doubling of all-cause mortality. During the past decade, limited success rates of drug treatment stimulated an exploration of interventional treatment options for AF. As our knowledge on initiating triggers and perpetuating substrate of AF expanded, different potentially curative catheter ablation techniques have been developed. In this article we review the current patient selection criteria, methods, and the results of the catheter ablation of atrial fibrillation.
心房颤动（AF）是一种常见的心律失常，据估计在美国有200万人受其影响，且其患病率随年龄增长而增加，在80岁及以上人群中达到10%。与普通人群相比，AF使中风风险增加4至5倍，并与全因死亡率翻倍相关。在过去十年中，药物治疗的成功率有限，促使人们探索AF的介入治疗选择。随着我们对AF起始触发因素和维持基质的认识不断扩展，已开发出不同的潜在治愈性导管消融技术。在本文中，我们回顾了目前心房颤动导管消融的患者选择标准、方法和结果。
